The short version of WADA prohibited list fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-02-06 and is reviewed periodically as new material appears.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
The strength and flexibility of carbon nanotubes makes them of potential use in controlling other nanoscale structures, which suggests they will have an important role in nanotechnology engineering. The highest tensile strength of an individual multi-walled carbon nanotube has been tested to be 63 GPa. Carbon nanotubes were found in Damascus steel from the 17th century, possibly helping to account for the legendary strength of the swords made of it. Recently, several studies have highlighted the prospect of using carbon nanotubes as building blocks to fabricate three-dimensional macroscopic (>1mm in all three dimensions) all-carbon devices. Lalwani et al. have reported a novel radical initiated thermal crosslinking method to fabricated macroscopic, free-standing, porous, all-carbon scaffolds using single- and multi-walled carbon nanotubes as building blocks. These scaffolds possess macro-, micro-, and nano- structured pores and the porosity can be tailored for specific applications. These 3D all-carbon scaffolds/architectures may be used for the fabrication of the next generation of energy storage, supercapacitors, field emission transistors, high-performance catalysis, photovoltaics, and biomedical devices and implants. CNTs are potential candidates for future via and wire material in nano-scale VLSI circuits. Eliminating electromigration reliability concerns that plague modern Cu interconnects, isolated (single and multi-wall) CNTs can carry current densities in excess of 1000 MA/cm2 without electromigration damage.
=== 15 July === The Russian-installed governor of Sevastopol claimed that a house was damaged by falling drone debris near Cape Fiolent. The Russian defence ministry claimed that six drones were shot down over Crimea. The HUR and volunteer hackers carried out a cyberattack on websites in Russia belonging to entities involved in the war effort against Ukraine. In Russia, the governor of Lipetsk Oblast claimed that an electrical substation was struck by a drone in Stanovlyansky District, while the governor of Bryansk Oblast claimed that 15 drones were shot down over five districts. Lithuania and Vilnius Combined Heat and Power Plant gave Ukraine equipment for a thermal power plant.
=== Pakistan === In Pakistan, the National Institute of Health (NIH) in Islamabad is the pioneer in laboratory sciences. The College of Medical Lab Technology (CMLT) of the NIH offers a two-year F.Sc degree in Medical Lab Technology (MLT). The previous two-year B.Sc. in MLT was discontinued and replaced by the four-year Bachelor Program in Medical Lab Sciences (MLS). The University of Health Sciences in Lahore also offers a four-year Bachelor program in MLS through approved colleges. The University of Lahore, University of Faisalabad, University of Sargodha, and Superior University in Lahore all offer a five-year Doctor of Medical Lab Sciences (DMLS) Program. Eligibility criteria for the four-year B.Sc. in MLS and the five-year Doctor of Medical Lab Sciences (DMLS) is the F.Sc. Pre-Medical.
Low-dose naltrexone (LDN) refers to daily naltrexone dosages that are roughly one-tenth or less of the standard opioid addiction treatment dosage. Most published research suggests a daily dosage of 4.5 mg, but this can vary by a few milligrams. LDN has been studied for the treatment of multiple chronic pain conditions, including fibromyalgia, multiple sclerosis, Crohn's disease, long COVID, and complex regional pain syndrome. Naltrexone is approved by the Food and Drug Administration (FDA) for medication-assisted treatment of alcoholism and opioid use disorder (OUD). Bernard Bihari's initial off-label usage of naltrexone in doses ranging from 1.5 mg to 3 mg as an adjuvant therapy for acquired immune deficiency syndrome (AIDS) in the 1980s led to the introduction of LDN into clinical practice. Due to a lack of large-scale clinical trials and standardized research aimed at determining appropriate indications for LDN, it has remained an off-label option.
Sources: en.wikipedia.org
They argued that the game simultaneously presents the player with numerous opportunities for action while restricting how its narrative can progress. This tension becomes explicit during Jack's confrontation with Ryan: after the player has spent much of the game directly controlling Jack, control is removed while Jack is compelled to kill Ryan. Aldred and Greenspan interpreted the sequence as exposing a distinction between the player's experience of autonomy and the predetermined structures governing both Jack and the player, and related this contradiction to the game's broader critique of technological progress and individual freedom. Stefan Schubert connected the same sequence to the game's use of Objectivism. He argued that Atlas initially resembles a conventional video-game guide, directing the player's actions in a manner that players have been conditioned by other games to accept without questioning. The revelation that Jack has been compelled to obey Atlas therefore operates on both a narrative and a metatextual level: Jack discovers the limits of his own autonomy while the player is made aware of having voluntarily followed substantially the same instructions. Schubert nevertheless rejected a simple conclusion that BioShock presents all choice as meaningless. He contrasted the predetermined confrontation with Ryan with the player's treatment of the Little Sisters, which can alter the game's ending, and argued that the game instead presents agency as limited and internally contradictory.
==== James H. Gilliam, Jr. College of Liberal Arts ==== The College of Liberal Arts offers degree programs in the arts, history, humanities, military and social sciences, and hosts two museums: the James E. Lewis Museum of Art and Lillie Carroll Jackson Civil Rights Museum. The James E. Lewis Museum of Art (JELMA) is the cultural extension of Morgan State University's Fine Arts academic program. The Lillie Carroll Jackson Civil Rights Museum illustrates the last recorded lynching in Maryland.
== Background == Peptides can serve as sturdy building blocks for a wide range of materials as they can be designed to combine with a range of other building blocks such as lipids, sugars, nucleic acids, metallic nanocrystals, and so on; this gives the peptides an edge over carbon nanotubes, which are another popular nanomaterial, as the carbon structure is unreactive. They also exhibit biocompatibility and molecular recognition; the latter is particularly useful as it enables specific selectivity for building ordered nanostructures. Additionally, peptides have superb resistance to extreme temperature, detergents, and denaturants. The ability of peptides to perform self-assembly allows them to be used as fabrication tools, which will continue to grow as a fundamental part of nanomaterials production. The self-assembling of peptides is facilitated through the molecules' structural and chemical compatibility with each other. The structures formed demonstrate physical and chemical stability. An advantage to using self-assembling peptides to build nanostructures in a bottom-up approach is that specific features can be incorporated; the peptides can be modified to serve specific functions. This approach means the final structures are made from the self-integration of small, simple building blocks. This approach is needed for nanoscale structure, as the top-down method of miniaturizing devices using sophisticated lithography and etching techniques has reached a physical limit.
== Legality == Brorphine is not controlled under the Single Convention on Narcotic Drugs, 1961, or under the Federal Analogue Act, but it could be illegal to sell, produce, possess or consume it in several countries if it is sold for human consumption. In the United States, brorphine was placed into temporary emergency Schedule I for 2 years by the DEA on January 4, 2021. On February 3, 2023, the DEA filed plans in the Federal Register for permanent placement of brorphine into Schedule I.
=== Cardiovascular disease === Beyond diabetes, RAGE is crucial in cardiovascular disease pathogenesis, particularly atherosclerosis. Although RAGE is present in atherosclerotic plaques in both diabetic and non-diabetic patients, its expression is heightened in diabetic individuals. RAGE activation in smooth muscle cells, endothelial cells, and macrophages promotes atherosclerotic lesion development through mechanisms involving oxidative stress, inflammatory signaling, and immune cell recruitment. RAGE-mediated signaling exacerbates vascular inflammation, endothelial dysfunction, and plaque instability. Animal studies demonstrate that blocking RAGE in diabetic models can reduce lesion formation and improve vascular function, even without affecting blood glucose levels.
Sources: en.wikipedia.org
== Medical uses == Medications based on incretins are used in the treatment of type 2 diabetes mellitus as well as the management of obesity. Most of the earliest incretin-targeting agents to be approved fell into the class of DPP-4 inhibitors; these inhibit DPP-4 and prevent the enzymatic degradation of GLP-1 and GIP. The first medication in this class, sitagliptin, received FDA approval in 2006 for the treatment of type 2 diabetes. GLP-1 analogs principally act as agonists of the GLP-1 receptor and are thus insulinotropic. Exenatide was the first drug in this class to be used in the treatment of type 2 diabetes; it received FDA approval in 2005. More recently, longer-acting and more potent GLP-1 analogs have been developed, most notably semaglutide, which received FDA approval for type 2 diabetes in 2017. It was subsequently approved for the management of obesity. In 2021, it was in the Top 100 most-prescribed drugs in the United States. Tirzepatide (sold as Mounjaro and Zepbound) is a potent GIP analog with agonist activity at GIP and GLP-1 receptors. It was approved for the treatment of type 2 diabetes in the United States in May 2022, and for the management of obesity in November 2023.
== Human sexual orientation and behavior genetics == In the 1990s Hamer began studies on the genetics of human behavior, which led to the first molecular evidence for genes that influence human sexual orientation. His research group's first paper, published in Science in 1993, reported that the maternal but not paternal male relatives of gay men had increased rates of same-sex orientation, suggesting the possibility of sex-linked transmission in a portion of the population. A genetic linkage analysis of DNA samples from these families showed that gay brothers had an increased probability of sharing polymorphic markers on the subtelomeric region of the long arm of the X chromosome, Xq28, providing statistically significant evidence for linkage to the sexual orientation phenotype. This finding was replicated in two other studies in the United States whereas a study in Canada found contrary results; meta-analysis of all data available at that time suggested that Xq28 has a significant but not exclusive effect. Subsequently, a genomewide scan by Hamerʻs group revealed additional regions on autosomes that were moderately linked to male sexual orientation. Hamer's results were supported in 2014 in a large, multi-center genetic linkage study of male sexual orientation. This study's analysis of 409 pairs of gay brothers with over 300,000 single-nucleotide polymorphism markers confirmed the Xq28 linkage by two-point and multipoint LOD score mapping.
=== Class III === Class III fusion proteins are distinct from I and II. They typically consist of five structural domains, where domains 1, 2 and 4 often contain more β-sheets and domains 3 and 5 are richer in α-helices (defining domain 1 as being closer to the N-terminus and 5 closer to the C-terminus). In the pre-fusion state, the domains nest, with domain 1 protected by domain 2, which is nested in domain 3, which is protected by domain 4. Domain 1 contains a bipartite site, likely for membrane fusion, within the loops connecting its long beta strands, and domain 5 serves as a linker between domain 4 and the C-terminal membrane-proximal and transmembrane domains. Domain 3 refolds upon fusion, while domain 5 loses its alpha helical structure.
=== Detection of MTHFR polymorphisms === A triplex tetra-primer ARMS-PCR method was developed for the simultaneous detection of C677T and A1298C polymorphisms with the A66G MTRR polymorphism in a single PCR reaction.
In March 2025, Cerebras announced plans to construct six new datacenters in Dallas, Minneapolis, Oklahoma City, Montreal, New York, and France, increasing inference capacity twentyfold to over 40 million tokens per second, expecting increased demand from Llama 4 and DeepSeek. Meta Platforms agreed to use Cerebras products to power the Llama API in April 2025. In April 2025, Cerebras and Ranovus announced a contract from DARPA. In May 2025, Cerebras beat NVIDIA's Blackwell in Llama 4 Inference with more than 2,500 tokens per second/user, compared to 1,000 for Blackwell, on the 400B-parameter Llama 4 Maverick model in testing by an independent benchmarking firm. In July 2025, Cerebras unveiled Qwen3-235B, an ultra-fast deployment of Alibaba Group's open-weight Qwen AI models, with full 131k context support on its inference cloud platform. In January 2026, Cerebras signed a deal with OpenAI to deliver 750 megawatts of computing power through 2028 for $10 billion. As part of the agreement with OpenAI, the company is temporarily prohibited from selling its products to Anthropic. In March 2026, Amazon Web Services agreed to purchase CS-3 systems to be used for its Trainium-powered servers set to be deployed on Amazon Bedrock in its data centers. In August 2026, CS-4 system was introduced.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.